Protea Biosciences, Inc. Announces Drug Development Partnership With Mayoly Spindler, a European Pharmaceutical Company
MORGANTOWN, W.Va., May 29, 2009 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leader in the development of new protein technology, announced today that it has entered into a drug development partnership with LABORATOIRES MAYOLY SPINDLER (Mayoly), a European pharmaceutical company based in France, that specializes in Gastroenterology therapeutics.